The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
Open accessAbstract
With the current trajectory of the 2019‐nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes. Although little is known about the virus, an examination of the genome sequence shows strong homology with its better‐studied cousin, SARS‐CoV. The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides. Other key drug targets, including RNA‐dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homology to SARS‐CoV. Herein, we suggest four potential drug candidates (an ACE2‐based peptide, remdesivir, 3CLpro‐1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019‐nCoV. We also summarize previous efforts into drugging these targets and hope to help in the development of broad‐spectrum anti‐coronaviral agents for future epidemics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Virus-encoded proteinases and proteolytic processing in the Nidovirales
Ziebuhr, J., Gorbalenya, A. E., & Snijder, E. J. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-4-853 · Cited by 1,029
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
Kirchdoerfer, R. N., & Ward, A. B. (2019) · Nature Communications · doi:10.1038/s41467-019-10280-3 · Cited by 896
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Protease inhibitors targeting coronavirus and filovirus entry
Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 583
Smith, E. C., Blanc, H., Vignuzzi, M., & Denison, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003565 · Cited by 444
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
Ferron, F., Subissi, L., Silveira De Morais, A. T., Le, N. T. T., Sevajol, M., Gluais, L., Decroly, E., Vonrhein, C., Bricogne, G., Canard, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718806115 · Cited by 404
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Cavanagh, D. (2003) · Avian Pathology · doi:10.1080/03079450310001621198 · Cited by 332
Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.003 · Cited by 322
O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., & DeGrado, W. F. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340140411 · Cited by 278
Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K.-O., & Pedersen, N. C. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005531 · Cited by 238
Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV
Park, J.-Y., Ko, J.-A., Kim, D. W., Kim, Y. M., Kwon, H.-J., Jeong, H. J., Kim, C. Y., Park, K. H., Lee, W. S., & Ryu, Y. B. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.1003215 · Cited by 231
Ratia, K., Kilianski, A., Baez-Santos, Y. M., Baker, S. C., & Mesecar, A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004113 · Cited by 224
Programmed ribosomal frameshifting in decoding the SARS-CoV genome
Baranov, P. V., Henderson, C. M., Anderson, C. B., Gesteland, R. F., Atkins, J. F., & Howard, M. T. (2005) · Virology · doi:10.1016/j.virol.2004.11.038 · Cited by 224
Xu, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg916 · Cited by 224
SARS coronavirus: a new challenge for prevention and therapy
Holmes, K. V. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18819 · Cited by 223
Jiang, S., He, Y., & Liu, S. (2005) · Emerging Infectious Diseases · doi:10.3201/1107.050219 · Cited by 215
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
Cheng, K.-W., Cheng, S.-C., Chen, W.-Y., Lin, M.-H., Chuang, S.-J., Cheng, I.-H., Sun, C.-Y., & Chou, C.-Y. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.011 · Cited by 186
Roper, R. L., & Rehm, K. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.43 · Cited by 180
M13 bacteriophage displaying disulfide-constrained microproteins
McLafferty, M. A., Kent, R. B., Ladner, R. C., & Markland, W. (1993) · Gene · doi:10.1016/0378-1119(93)90149-w · Cited by 175
Lee, T.-W., Cherney, M. M., Huitema, C., Liu, J., James, K. E., Powers, J. C., Eltis, L. D., & James, M. N. G. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.004 · Cited by 170
Park, J.-Y., Jae Jeong, H., Hoon Kim, J., Min Kim, Y., Park, S.-J., Kim, D., Hun Park, K., Song Lee, W., & Bae Ryu, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00623 · Cited by 170
Hipolito, C. J., & Suga, H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.02.014 · Cited by 147
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908713 · Cited by 116
Self-citationKumar, V., Shin, J. S., Shie, J., Ku, K. B., Kim, C., Go, Y. Y., Huang, K.-F., Kim, M., & Liang, P. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.02.007 · Cited by 100
Liu, W., Zhu, H.-M., Niu, G.-J., Shi, E.-Z., Chen, J., Sun, B., Chen, W., Zhou, H., & Yang, C. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.028 · Cited by 98
Self-citationPapain-Like Protease (PLpro) Inhibitory Effects of Cinnamic Amides from Tribulus terrestris Fruits
Song, Y. H., Kim, D. W., Long, M. J. C., Yuk, H. J., Wang, Y., Zhuang, N., Lee, K. H., Jeon, K. S., & Park, K. H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00026 · Cited by 92
Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
He, R., Adonov, A., Traykova-Andonova, M., Cao, J., Cutts, T. A., Grudeski, E., Deschambaul, Y., Berry, J., DREBOT, M. A., & Li, X. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.076 · Cited by 84
Chen, X., Chou, C., & Chang, G. (2009) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020901900402 · Cited by 79
Xiao, W., Wang, Y., Lau, E. Y., Luo, J., Yao, N., Shi, C., Meza, L., Tseng, H. P., Maeda, Y., Kumaresan, P. R., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0308 · Cited by 77
Muller, M. P., Dresser, L., Raboud, J., McGeer, A., Rea, E., Richardson, S. E., Mazzulli, T., Loeb, M. B., & Louie, M. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.4.494 · Cited by 75
Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses
Kim, Y., Shivanna, V., Narayanan, S. K., Prior, A. M., Weerasekara, S., Hua, D. H., Kankanamalage, A. C. G., Groutas, W. C., & Chang, K. (2015) · Journal of Virology · doi:10.1128/jvi.03688-14 · Cited by 74
Repurposing host-based therapeutics to control coronavirus and influenza virus
Li, C.-C., Wang, X.-J., & Wang, H. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.01.018 · Cited by 72
Adverse Effects of Ribavirin and Outcome in Severe Acute Respiratory Syndrome
Chiou, H.-E., Liu, C., Buttrey, M. J., Kuo, H.-P., Liu, H.-W., Kuo, H.-T., & Lu, Y.-T. (2005) · CHEST Journal · doi:10.1378/chest.128.1.263 · Cited by 69
Navas, S., & Weiss, S. R. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490280292 · Cited by 64
Yap, Y., Zhang, X., Andonov, A. P., & He, R. (2005) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2005.04.006 · Cited by 43
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., Wang, D., Hayatshahi, H. S., Shen, Y., Liu, J., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201908713 · Cited by 24
Self-citationBacterial Cell‐Surface Display of Semisynthetic Cyclic Peptides
Palei, S., Becher, K.-S., Nienberg, C., Jose, J., & Mootz, H. D. (2018) · ChemBioChem · doi:10.1002/cbic.201800552 · Cited by 22
Cited by
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Huang, Y., Yang, C., Xu, X.-F., Xu, W., & Liu, S.-W. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,224
COVID-19 outbreak: Migration, effects on society, global environment and prevention
Chakraborty, I., & Maity, P. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138882 · Cited by 1,789
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00272 · Cited by 1,297
Metadata
- Authors
- Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R.
- Venue
- ChemBioChem
- Publisher
- Wiley
- Published
- 2020-02-25
- Volume
- 21
- Issue
- 5
- Pages
- 730-738
- ISSN
- 1439-4227 (ISSN-L)
- 1439-7633
- OpenAlex
- W3005527412
- Cited by
- 776
- References
- 44
- FWCI
- 20.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.